Annual results show sales and profit growing together. Sales rose from KRW 49.4 billion in 2022 to KRW 93.4 billion in 2023 (up 89.2%), KRW 129.7 billion in 2024 (up 38.9%) and KRW 154.1 billion in 2025 (up 18.8%), an increase in each year from 2023 through 2025, and 2025 was the largest year in the 2022 to 2025 span.
Operating profit moved from an operating loss of KRW 2.72 billion in 2022 to a profit of KRW 14.8 billion in 2023, the turn to profitability, then KRW 21.8 billion in 2024 (up 47.3%) and KRW 29 billion in 2025 (up 33.1%), two consecutive years of growth from 2024 to 2025.
Operating margin rose from -5.5% in 2022 to 15.8% in 2023, 16.8% in 2024 and 18.8% in 2025.
Net profit attributable to controlling shareholders stayed negative at a loss of KRW 11.2 billion in 2022 and KRW 8.88 billion in 2023, turned to a profit of KRW 5.58 billion in 2024, and reached KRW 34.7 billion in 2025 (up 522.5%).
Net profit including non-controlling interests was KRW 35.5 billion in 2025 and should be read separately from profit attributable to controlling shareholders. Operating cash flow moved from -KRW 10 billion in 2022 and -KRW 8.09 billion in 2023 to KRW 14.5 billion in 2024 and KRW 40.5 billion in 2025.
The company stated that 2025 consolidated sales and operating profit were record levels.
Quarterly sales peaked at KRW 45.1 billion in the third quarter of 2025, fell to KRW 29.7 billion in the fourth quarter (down 34.0% from the prior quarter), recovered to KRW 46.9 billion in the second quarter of 2026, and reached KRW 45.6 billion in the third quarter (down 2.8% from the prior quarter).
Fourth-quarter 2025 profit attributable to controlling shareholders rose 127.6% to KRW 13.7 billion while operating profit was KRW 7.39 billion, so the two measures moved in opposite directions.
In the first quarter of 2026, SK Securities estimated that real domestic growth was about 50% after excluding roughly KRW 4.5 billion of cosmetic-surgery-related refund sales in the prior-year quarter. Second-quarter 2026 operating profit of KRW 9.04 billion rose 55.3% from the prior quarter. Profit attributable to controlling shareholders over the last four quarters totals KRW 37.3 billion.